Dehydroepiandrosterone sulfate (DHEA-S) is an endogenous steroid hormone primarily produced by the adrenal cortex in response to adrenocorticotrophin (ACTH). It belongs to the chemical class of adrenal hormones and is a sulfated metabolite of dehydroepiandrosterone (DHEA). DHEA-S circulates in the blood, predominantly bound to albumin, with a small fraction remaining unbound. Researchers have found that DHEA-S plays a significant role in mammalian reproduction, acting as a precursor in the synthesis of androgens and estrogens. It is involved in ovarian follicular steroidogenesis and is considered a potential 'oocyte factor' that may trigger calcium oscillations necessary for oocyte activation. DHEA-S has been linked to skeletal maturation during puberty and is used as a non-invasive biomarker for detecting pubertal growth spurts. The mechanism of action of DHEA-S involves its conversion to active androgens and estrogens in peripheral tissues, which then interact with their respective receptors to exert biological effects. DHEA-S is also implicated in emotional processing, potentially modulating brain regions involved in negative emotion generation and enhancing attention and working memory. Pharmacokinetically, DHEA-S has a slower metabolic clearance rate compared to DHEA, with an MCR of approximately 131/day. It interconverts with DHEA, with a significant portion of DHEA-S converting back to DHEA. Clinically, DHEA-S is used in assisted reproductive technologies and has been studied for its potential benefits in various physiological and psychological conditions. However, its regulatory status varies across different countries, and it is not universally approved for all clinical uses.